SCOPUS 정보 검색 플랫폼

Pharmacogenetics

Volumn 11, Issue 8, 2001, Pages 735-737

Early acenocoumarol overanticoagulation among cytochrome P450 2C9 poor metabolizers

(7) Verstuyft, C a Morin, S a Robert, A a Loriot, M A a Beaune, P a Jaillon, P a Becquemont, L a

a SORBONNE UNIVERSITÉ (France)

Author keywords

Acenocoumarol; Cytochrome P450 2C9; Overanticoagulation; Pharmacogenetic

Indexed keywords

ACENOCOUMAROL; CYTOCHROME P450 2C9; WARFARIN;

ADULT; AGED; ALLELISM; ANTICOAGULATION; ARTICLE; BLEEDING; CASE REPORT; DRUG METABOLISM; DRUG OVERDOSE; FEMALE; GENOTYPE; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; PHARMACOGENETICS; PRIORITY JOURNAL;

ACENOCOUMAROL; ADOLESCENT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ARYL HYDROCARBON HYDROXYLASES; BLOOD COAGULATION DISORDERS; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MUTATION; STEROID 16-ALPHA-HYDROXYLASE; STEROID HYDROXYLASES;

EID: 0035171326 PISSN: 0960314X EISSN: None Source Type: Journal
DOI: 10.1097/00008571-200111000-00013 Document Type: Article

Times cited : (50)

References (11)

1
- 0033608466
- Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications
- (1999) Lancet , vol.353 , pp. 717-719
- Aithal, G.P.¹ Day, C.P.² Kesteven, P.J.³ Daly, A.K.⁴

2
- 0024330636
- The incidence and clinical significance of amiodarone and acenocoumarol interaction
- (1989) Thromb Haemost , vol.62 , pp. 906-908
- Caraco, Y.¹ Chajek-Shaul, T.²

3
- 0030891053
- Inhibition rather than enhancement of hemostatic system activation during initiation of oral anticoagulant treatment
- (1997) Thromb Haemost , vol.77 , pp. 684-689
- Kyrle, P.A.¹ Brockmeier, J.² Weltermann, A.³ Eichenger, S.⁴ Speiser, W.⁵ Lechner, K.⁶

4
- 0033694203
- Genetic modulation of oral anticoagulation with warfarin
- (2000) Thromb Haemost , vol.84 , pp. 775-778
- Margaglione, M.¹ Colaizzo, D.² Andrea, G.³ Brancaccio, V.⁴ Ciampa, A.⁵ Grandone⁶

5
- 0033603930
- CYP2C9*3 allelic variant and bleeding complications
- (1999) Lancet , vol.354 , pp. 1124
- Ogg, M.S.¹ Brennan, P.² Meade, T.³ Humphries, S.E.⁴

6
- 0030868485
- Genetic association between sensitivity to warfarin and expression of CYP2C9*3
- (1997) Pharmacogenetics , vol.7 , pp. 361-367
- Steward, D.J.¹ Haining, R.L.² Henne, K.R.³ Davis, G.⁴ Rushmore, T.H.⁵ Trager, W.F.⁶

7
- 0029798351
- Genetic analysis of the human cytochrome P450 CYP2C9 locus
- (1996) Pharmacogenetics , vol.6 , pp. 429-439
- Stubbins, M.J.¹ Harries, L.W.² Smith, G.³ Tarbit, M.H.⁴ Wolf, C.R.⁵

8
- 0034283762
- Influence of cytochrome P-450 CYP2C9 polymorphisms on warfarin sensitivity and risk of overanticoagulation in patients on long-term treatment
- (2000) Blood , vol.96 , pp. 1816-1819
- Taube, J.¹ Halsall, D.² Baglin, T.³

9
- 0033786365
- Cytochrome P4502C9 is the principal catalyst of racemic acenocoumarol hydroxylation reactions in human liver microsomes
- (2000) Drug Metab Dispos , vol.28 , pp. 1284-1290
- Thijssen, H.H.¹ Flinois, J.P.² Beaune, P.H.³

10
- 0033625822
- The possession of the CYP2C9*3 allele is associated with low dose requirement of acenocoumarol
- (2000) Pharmacogenetics , vol.10 , pp. 757-760
- Thijssen, H.¹ Verkooijen, I.² Frank, H.³

11
- 0033608176
- Validation of methods for CYP2C9 genotyping: Frequencies of mutant alleles in a Swedish population
- (1999) Biochem Biophys Res Commun , vol.254 , pp. 628-631
- Yasar, M.¹ Eliasson, E.² Dahl, M.L.³ Johansson, I.⁴ Ingelman-Sundberg, M.⁵ Sjoqvist, F.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.